標題: Titlebook: Cardio-Oncology; The Clinical Overlap Gretchen G. Kimmick,Daniel J. Lenihan,Dawn L. Hers Book 2017 Springer International Publishing Switze [打印本頁] 作者: DIGN 時間: 2025-3-21 17:59
書目名稱Cardio-Oncology影響因子(影響力)
書目名稱Cardio-Oncology影響因子(影響力)學(xué)科排名
書目名稱Cardio-Oncology網(wǎng)絡(luò)公開度
書目名稱Cardio-Oncology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cardio-Oncology被引頻次
書目名稱Cardio-Oncology被引頻次學(xué)科排名
書目名稱Cardio-Oncology年度引用
書目名稱Cardio-Oncology年度引用學(xué)科排名
書目名稱Cardio-Oncology讀者反饋
書目名稱Cardio-Oncology讀者反饋學(xué)科排名
作者: dowagers-hump 時間: 2025-3-21 22:48 作者: Blazon 時間: 2025-3-22 01:26
Vascular Complications of Cancer and Cancer Therapy,n improving cancer patient survival exists. This chapter discusses risk of and indications for thromboprophylaxis for venous thromboembolism in cancer patients and explores the epidemiologic and mechanistic relationship between certain cancer therapies and risk of vascular complications including venous thromboembolism and arterial thrombosis.作者: 共和國 時間: 2025-3-22 04:47
Geriatric Cardio-oncology,y is recommended as a strategy to improve outcomes. Aggressive screening of risk factors, early detection of cardiovascular injury, and close collaboration between oncologists and cardiologists are critical for optimizing cardiovascular health and cancer outcomes in older patients.作者: 相符 時間: 2025-3-22 11:40 作者: sclera 時間: 2025-3-22 12:53 作者: sclera 時間: 2025-3-22 17:25 作者: Outwit 時間: 2025-3-22 22:04
https://doi.org/10.1007/b137669ention of major national and international cardiology and oncology associations to the field of cardio-oncology. This chapter discusses how the partnership of these two medical subspecialties in the future will improve outcomes for cancer patients.作者: COST 時間: 2025-3-23 03:36
Management of Chemotherapy-Associated Cardiomyopathy,re many well-documented, long-term cardiovascular complications of chemotherapy including cardiomyopathy, myocardial infarction, and arrhythmia [2]. This chapter will focus on the management of cancer treatment-induced cardiomyopathy.作者: 標準 時間: 2025-3-23 05:39 作者: 領(lǐng)先 時間: 2025-3-23 10:41 作者: faction 時間: 2025-3-23 13:59
,Gastrointestinale und abdominale Notf?lle,s the cellular and molecular mechanisms of radiation-induced heart disease, elucidating opportunities for intervention and prevention. Finally, recommendations for monitoring patients after radiotherapy and management of cardiac disease in patients with prior thoracic/breast neoplasms will be discussed.作者: Nerve-Block 時間: 2025-3-23 18:38
Die Grunds?tze der Neugeborenenreanimationogic, and radiation therapies. Less well understood is the potential that cancers and cardiovascular diseases share common genetic susceptibilities. An appreciation of the converging epidemiology for cancer and heart disease will lay the foundation for developing prevention and treatment strategies.作者: 易碎 時間: 2025-3-23 23:22
,Gastrointestinale und abdominale Notf?lle,equire a dynamic partnership between oncologists and cardiologists, and the development of a new generation of “cardio-oncology” clinicians and investigators. Organized collaboration between oncologists, cardiologists, and regulatory agencies can support development of programs essential for anticancer agents with cardiac safety concerns.作者: cardiovascular 時間: 2025-3-24 04:20
,St?rungen der Vitalfunktionen,chapter will address basic assessment and management of cardiac function and risk in cancer survivors. Best practices for assessment of survivors based on treatment modality (i.e., chemotherapy and/or radiation therapy) and host-related factors (i.e., age at diagnosis and pre-existing risk factors) are described.作者: amenity 時間: 2025-3-24 09:33
Epidemiology of Cardio-Oncology,ogic, and radiation therapies. Less well understood is the potential that cancers and cardiovascular diseases share common genetic susceptibilities. An appreciation of the converging epidemiology for cancer and heart disease will lay the foundation for developing prevention and treatment strategies.作者: 易改變 時間: 2025-3-24 13:46 作者: 亞當心理陰影 時間: 2025-3-24 15:00
Cardiac Toxic Chemotherapy and Cancer Survivorship,chapter will address basic assessment and management of cardiac function and risk in cancer survivors. Best practices for assessment of survivors based on treatment modality (i.e., chemotherapy and/or radiation therapy) and host-related factors (i.e., age at diagnosis and pre-existing risk factors) are described.作者: Nomogram 時間: 2025-3-24 22:00
Preoperative and Pre-transplant Cardiac Evaluation in the Cancer Patient,rd to patient-specific risk factors, the underlying disease, and the transplant procedures. Guidelines for the pre-transplant evaluation and prevention and monitoring for cardiovascular complications during the course of stem cell transplant are discussed.作者: FLAG 時間: 2025-3-25 00:31
Radiation Therapy and Cardiotoxicity,s the cellular and molecular mechanisms of radiation-induced heart disease, elucidating opportunities for intervention and prevention. Finally, recommendations for monitoring patients after radiotherapy and management of cardiac disease in patients with prior thoracic/breast neoplasms will be discussed.作者: 挫敗 時間: 2025-3-25 06:20 作者: gregarious 時間: 2025-3-25 10:11 作者: 使迷醉 時間: 2025-3-25 12:58 作者: 一條卷發(fā) 時間: 2025-3-25 16:12
https://doi.org/10.1007/978-3-319-43096-6cancer; cardio-oncology; geriatric; heart disease; survivorship; treatment complications作者: famine 時間: 2025-3-25 22:18 作者: membrane 時間: 2025-3-26 03:02
Kardiopulmonale Reanimation (CPR),Coronary artery disease (CAD) and cancer share the same demographics and also lifestyle factors?to a certain degree. The age groups where cancer is more common are also the age groups where CAD is common. After age 25, cardiac disease, primarily CAD, and malignancy are the two most common causes of death in adults [1, 2] (Fig. 8.1).作者: 刺激 時間: 2025-3-26 07:49
Management of Patients with Coronary Disease and Cancer: Interactions Between Cancer, Cancer TreatmCoronary artery disease (CAD) and cancer share the same demographics and also lifestyle factors?to a certain degree. The age groups where cancer is more common are also the age groups where CAD is common. After age 25, cardiac disease, primarily CAD, and malignancy are the two most common causes of death in adults [1, 2] (Fig. 8.1).作者: Gene408 時間: 2025-3-26 08:48
Die Grunds?tze der Neugeborenenreanimationergence. On the one hand, there are modifiable risk factors, which, along with aging, influence risk of cardiovascular disease (CVD) and specific malignancies. Emerging evidence suggests that inflammation might be one of the common mechanisms linking diet, obesity, tobacco use, and time to these two作者: Rebate 時間: 2025-3-26 15:51
Ch. Herfarth,H. Goebell,J. Hornparticipating general practitioners, cardiologists, and oncologists. Given the increasing number of cancer survivors, development of cardiotoxicity associated with anticancer therapy represents a complex clinical challenge and a major economic and health burden. Additionally, a large number of cance作者: 知道 時間: 2025-3-26 20:16 作者: 寵愛 時間: 2025-3-27 00:45
Chirurgische Aspekte der pulmonalen Notf?lleular complications of cancer therapies has increased with the introduction of novel combinations and with new targeted biologic therapies [1]. There are many well-documented, long-term cardiovascular complications of chemotherapy including cardiomyopathy, myocardial infarction, and arrhythmia [2]. T作者: cyanosis 時間: 2025-3-27 02:33 作者: 破譯 時間: 2025-3-27 06:06 作者: condemn 時間: 2025-3-27 12:59 作者: 懶鬼才會衰弱 時間: 2025-3-27 14:01 作者: Nomogram 時間: 2025-3-27 19:29 作者: 1FAWN 時間: 2025-3-28 00:19 作者: floaters 時間: 2025-3-28 03:35 作者: NATTY 時間: 2025-3-28 06:22
https://doi.org/10.1007/b137669ion between the specialties of oncology and cardiology. Collaboration is developing in the clinic, research, and training arenas and has drawn the attention of major national and international cardiology and oncology associations to the field of cardio-oncology. This chapter discusses how the partne作者: 樸素 時間: 2025-3-28 14:01
Epidemiology of Cardio-Oncology,ergence. On the one hand, there are modifiable risk factors, which, along with aging, influence risk of cardiovascular disease (CVD) and specific malignancies. Emerging evidence suggests that inflammation might be one of the common mechanisms linking diet, obesity, tobacco use, and time to these two作者: 廢除 時間: 2025-3-28 14:56 作者: bile648 時間: 2025-3-28 19:53
Screening and Monitoring for Cardiotoxicity During Cancer Treatment,led to increased survivorship; however, these treatments may contribute to cardiovascular morbidity and mortality that threaten to undermine cancer-specific survival gains. The new subspecialty of “cardio-oncology” aims to keep pace with the rapid evolution of cancer therapies and the incidence, mag作者: 笨拙的我 時間: 2025-3-29 02:19
Management of Chemotherapy-Associated Cardiomyopathy,ular complications of cancer therapies has increased with the introduction of novel combinations and with new targeted biologic therapies [1]. There are many well-documented, long-term cardiovascular complications of chemotherapy including cardiomyopathy, myocardial infarction, and arrhythmia [2]. T作者: 考得 時間: 2025-3-29 03:12 作者: 減震 時間: 2025-3-29 07:25 作者: 百靈鳥 時間: 2025-3-29 14:15
Radiation Therapy and Cardiotoxicity,pidemiology of heart disease after radiotherapy, with specific focus on clinical data from Hodgkin lymphoma?and breast cancer survivors. As clinical manifestation of heart disease can take years, if not decades, to manifest, animal models can assist in our understanding of the pathogenesis as well a作者: intrigue 時間: 2025-3-29 16:09 作者: CROAK 時間: 2025-3-29 23:30 作者: 典型 時間: 2025-3-30 03:20 作者: FOLLY 時間: 2025-3-30 04:02
Geriatric Cardio-oncology,ly vulnerable to cardiotoxicity from cancer treatment. Cardiotoxicity results from several factors in older patients: age-related factors, direct cardiac injury related to certain chemotherapy drugs (anthracyclines, trastuzumab, tyrosine kinase inhibitors, platinums, etc.), and changes in functional作者: MIME 時間: 2025-3-30 11:13
Future Clinical and Professional Directions in Cardio-oncology,ion between the specialties of oncology and cardiology. Collaboration is developing in the clinic, research, and training arenas and has drawn the attention of major national and international cardiology and oncology associations to the field of cardio-oncology. This chapter discusses how the partne作者: 一起平行 時間: 2025-3-30 14:42 作者: 出價 時間: 2025-3-30 20:14
Screening and Monitoring for Cardiotoxicity During Cancer Treatment,dalities such as cardiac MRI or strain imaging by echocardiography, functional capacity testing, blood-based biomarkers, and genetic testing, but no best approach or combination of approaches has clearly emerged. Research evaluating the role of these alternative techniques as well as their optimal t
